- Investing Ideas
- Bangladeshi Pharmaceuticals & Biotech Potentially Undervalued Companies
Bangladeshi Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
5
Companies with a Value score of at least 3, ordered by Value score
5 companies
Square Pharmaceuticals
Market Cap: ৳193.4b
Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳218.20
7D
-1.6%
1Y
-0.6%
Beximco Pharmaceuticals
Market Cap: ৳66.3b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally.
BXPHARMA
৳148.70
7D
-1.7%
1Y
39.1%
ACME Laboratories
Market Cap: ৳17.8b
A pharmaceutical company, engages in the manufacturing, marketing, and distribution of generic pharmaceutical formulation products in Bangladesh.
ACMELAB
৳83.90
7D
-0.5%
1Y
8.0%
Navana Pharmaceuticals
Market Cap: ৳7.8b
Engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh.
NAVANAPHAR
৳72.50
7D
-1.5%
1Y
32.8%
Renata
Market Cap: ৳55.0b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.
RENATA
৳479.10
7D
1.7%
1Y
-6.3%